Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

The terms of the agreement entail that Eli Lilly and Company (NYSE:LLY) would acquire all the outstanding shares of Ventyx ...

Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

The project was secured by a Jobs, Energy, Technology and Innovation Act (JETI) tax agreement, which includes a school tax ...

The big lure for Eli Lilly to build a $6.5 billion pharmaceuticals plant in Houston is now official — and details are out on ...

An approval of Lilly's pill, along with its current strength in the weight loss market, could equal revenue growth well into ...

The about-$1 billion deal could come imminently.

BRANCHBURG – Korean pharmaceutical firm Celltrion has launched operations at the former Eli Lilly facilities on Imclone Drive ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...

Aktis Oncology Inc. shares jumped 24 percent in their trading debut after the clinical-stage biotechnology company raised ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...